Mainz Biomed NV (MYNZ)
(Delayed Data from NSDQ)
$0.26 USD
+0.01 (3.73%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $0.26 0.00 (0.66%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/21/24 |
---|---|
Current Quarter | -0.25 |
EPS Last Quarter | NA |
Last EPS Surprise | NA |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.88 |
Next Year | NA |
EPS (TTM) | -1.64 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.30M | 0.35M | 1.30M | NA |
# of Estimates | 1 | 1 | 1 | NA |
High Estimate | 0.30M | 0.35M | 1.30M | NA |
Low Estimate | 0.30M | 0.35M | 1.30M | NA |
Year ago Sales | 0.25M | 0.18M | 0.90M | 1.30M |
Year over Year Growth Est. | 20.00% | 94.44% | 45.09% | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.25 | -0.18 | -0.88 | NA |
# of Estimates | 1 | 1 | 2 | NA |
Most Recent Consensus | -0.25 | -0.18 | -0.88 | NA |
High Estimate | -0.25 | -0.18 | -0.84 | NA |
Low Estimate | -0.25 | -0.18 | -0.91 | NA |
Year ago EPS | -0.56 | -0.39 | -1.62 | -0.88 |
Year over Year Growth Est. | 55.36% | 53.85% | 45.68% | NA |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | NA |
Up Last 30 Days | 0 | 0 | 0 | NA |
Up Last 60 Days | 0 | 0 | 0 | NA |
Down Last 7 Days | 0 | 0 | 0 | NA |
Down Last 30 Days | 0 | 0 | 0 | NA |
Down Last 60 Days | 0 | 0 | 0 | NA |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.25 | -0.18 | -0.88 | NA |
7 Days Ago | -0.25 | -0.18 | -0.88 | NA |
30 Days Ago | -0.25 | -0.18 | -0.88 | NA |
60 Days Ago | -0.25 | -0.18 | -0.88 | NA |
90 Days Ago | -0.25 | -0.18 | -0.88 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.25 | -0.18 | -0.88 | NA |
Zacks Consensus Estimate | -0.25 | -0.18 | -0.88 | NA |
Earnings ESP | 0.00% | 0.00% | 0.00% | NA |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | NA | -0.24 | -0.39 | -0.56 | NA |
Estimate | NA | NA | -0.50 | -0.44 | NA |
Difference | NA | NA | 0.11 | -0.12 | -0.01 |
Surprise | NA | NA | 22.00% | -27.27% | -2.64% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more